Not every cluster that is popping up these days is a bad thing: located right in the heart of the Vienna BioCenter, the newly installed Cloud Infrastructure Platform (CLIP) is the country’s largest non-university supercomputer cluster. It has…

Merve Deniz Abdusselamoglu, alumna from Jürgen Knoblich’s lab at IMBA, is awarded the Kirsten Peter Rabitsch Award for the best PhD thesis at IMP and IMBA.

A new method developed by researchers of the Vienna BioCenter, SARSeq, will allow testing of thousands of samples for SARS-CoV-2 and other pathogens in just 15 to 24 hours. One area of application could be the monitoring of large groups of people,…

Researchers from the laboratory of Jürgen Knoblich at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – developed CRISPR-LICHT, a revolutionary technology that allows genetic screens in human tissues such as brain…

Scientists from the Vienna BioCenter developed a new SARS-CoV-2 detection method: by rather simple means, their RT-LAMP test is cheaper than PCR testing and achieves results with comparable sensitivity and specificity. The Austrian Agency for Health…

IMBA´s scientific director Jürgen Knoblich has been accepted into the Pontifical Academy of Sciences. This was announced by the Vatican on Friday, September 25th.

An international team of researchers with the participation of IMBA - Institute for Molecular Biotechnology of the Austrian Academy of Sciences – shows, by means of a case study in the renowned specialist magazine The Lancet Respiratory Medicine, how…

Proper folding of extremely long chromosomal DNA molecules is crucial for the correct functioning of the cell. Scientists from the Gerlich lab at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – developed a…

Scientists from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the University of British Columbia have discovered a major role of the protein JAGN1 in antibody production and the body’s ability to mount a…

A new role for Casein Kinase-1 on RNF43 is identified – Study by Tadasuke Tsukiyama and IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences group leader Bon-Kyoung Koo published in Nature Communications